𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erratum: Delaney G, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence. Cancer. 2004; 101(4):657–60.

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
21 KB
Volume
107
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The original article to which this Erratum refers was published in Cancer (2004) 101(4):657–60

📜 SIMILAR VOLUMES

Estimation of an optimal radiotherapy ut
Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma : A review of the evidence
✍ Geoff Delaney; Michael Barton; Susannah Jacob 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 1 views

## Abstract ## BACKGROUND Radiotherapy utilization rates for cancer vary widely, both within and between countries. The optimal proportion of patients with gastrointestinal malignancies who should receive at least one course of radiotherapy at some time during their illness is an important benchma

Estimation of an optimal radiotherapy ut
Estimation of an optimal radiotherapy utilization rate for breast carcinoma : A review of the evidence
✍ Geoff Delaney; Michael Barton; Susannah Jacob 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

## Abstract ## BACKGROUND Radiotherapy utilization rates for breast carcinoma vary widely, both within and between countries. Current estimates of the proportion of patients with carcinoma who optimally should receive radiotherapy are based either on expert opinion or on the measurement of actual

Estimation of an optimal radiotherapy ut
Estimation of an optimal radiotherapy utilization rate for melanoma : A review of the evidence
✍ Geoff Delaney; Michael Barton; Susannah Jacob 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract ## BACKGROUND Radiotherapy is not used commonly in the treatment of patients with malignant melanoma. The benchmark optimal radiotherapy utilization rates for melanoma are largely unknown, despite the fact that melanoma is a very common cancer. ## METHODS To develop an evidence‐based